UV-A1 phototherapy improves nephrogenic fibrosing dermopathy

Arch Dermatol. 2004 Nov;140(11):1322-4. doi: 10.1001/archderm.140.11.1322.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Collagen Type I / genetics
  • Collagen Type III / genetics
  • Connective Tissue Growth Factor
  • Female
  • Fibrosis
  • Humans
  • Immediate-Early Proteins / genetics
  • Intercellular Signaling Peptides and Proteins / genetics
  • Kidney Diseases / complications*
  • Leg Dermatoses / etiology*
  • Leg Dermatoses / metabolism
  • Leg Dermatoses / pathology
  • Leg Dermatoses / therapy*
  • Middle Aged
  • RNA, Messenger / metabolism
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta1
  • Ultraviolet Therapy*

Substances

  • CCN2 protein, human
  • Collagen Type I
  • Collagen Type III
  • Immediate-Early Proteins
  • Intercellular Signaling Peptides and Proteins
  • RNA, Messenger
  • TGFB1 protein, human
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1
  • Connective Tissue Growth Factor